OR WAIT null SECS
May 02, 2016
In a move to encourage drug development, EU regulators are offering scientific advice to companies on major efficacy, safety, and quality issues at an early stage.
April 07, 2016
The campaign against opioid abuse opens door to more innovative therapies.
April 02, 2016
Global outbreaks energize vaccine R&D and drive production modernization.
March 02, 2016
Policy makers debate strategies for promoting access to less costly medicines.
The EU is striving to reduce the costs and administrative burden facing pharmaceutical manufacturers when complying with variations regulations for keeping authorization dossiers up to date.
February 02, 2016
FDA and industry see progress and challenges in bringing cutting-edge medicines to patients.
February 01, 2016
The EU’s key objectives include improving medicines access, tackling drug shortages, and increasing administrative efficiency in its regulatory framework.
January 02, 2016
The bio/pharmaceutical industry will face increased scrutiny of product quality and cost drivers.
December 02, 2015
FDA confirmed quality focus while Congress moved to bolster biomedical innovation.
November 02, 2015
New program emphasizes quality, risk, and global collaboration.